rs374059459

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000308.4(CTSA):​c.1009G>A​(p.Ala337Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A337P) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

CTSA
NM_000308.4 missense

Scores

19

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.890

Publications

1 publications found
Variant links:
Genes affected
CTSA (HGNC:9251): (cathepsin A) This gene encodes a member of the peptidase S10 family of serine carboxypeptidases. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate two chains that comprise the heterodimeric active enzyme. This enzyme possesses deamidase, esterase and carboxypeptidase activities and acts as a scaffold in the lysosomal multienzyme complex. Mutations in this gene are associated with galactosialidosis. [provided by RefSeq, Nov 2015]
CTSA Gene-Disease associations (from GenCC):
  • galactosialidosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, ClinGen, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0887337).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CTSANM_000308.4 linkc.1009G>A p.Ala337Thr missense_variant Exon 11 of 15 ENST00000646241.3 NP_000299.3 P10619-1X6R8A1
CTSANM_001127695.3 linkc.1009G>A p.Ala337Thr missense_variant Exon 11 of 15 NP_001121167.1 P10619-1
CTSANM_001167594.3 linkc.958G>A p.Ala320Thr missense_variant Exon 10 of 14 NP_001161066.2 P10619-2B4E324X6R5C5
CTSANR_133656.2 linkn.1061G>A non_coding_transcript_exon_variant Exon 11 of 15

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CTSAENST00000646241.3 linkc.1009G>A p.Ala337Thr missense_variant Exon 11 of 15 NM_000308.4 ENSP00000493613.2 P10619-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1461882
Hom.:
0
Cov.:
68
AF XY:
0.00000413
AC XY:
3
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1112006
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.088
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
2.0
DANN
Benign
0.84
DEOGEN2
Benign
0.21
T;.;T;T;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.088
N
LIST_S2
Benign
0.74
T;T;.;.;T
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.089
T;T;T;T;T
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
0.050
.;.;N;N;N
PhyloP100
-0.89
PrimateAI
Benign
0.23
T
PROVEAN
Benign
0.020
N;N;.;N;.
REVEL
Benign
0.23
Sift
Benign
0.56
T;T;.;T;.
Sift4G
Benign
0.58
T;T;.;T;T
Polyphen
0.0
.;.;B;B;B
Vest4
0.11
MutPred
0.67
.;.;Gain of glycosylation at A337 (P = 0.0251);Gain of glycosylation at A337 (P = 0.0251);Gain of glycosylation at A337 (P = 0.0251);
MVP
0.68
MPC
0.37
ClinPred
0.039
T
GERP RS
-11
Varity_R
0.21
gMVP
0.36
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374059459; hg19: chr20-44523693; API